Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-02-20

Clinical Trial Update: Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy [NA]

View source ↗

Summary

A clinical trial evaluating the analgesic effect of pregabalin in patients undergoing total abdominal hysterectomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Northwestern University | Conditions: Pain | NA | Status: WITHDRAWN